FIGURE

Fig. 3

ID

ZDB-FIG-210825-3

Publication

Watchon et al., 2021 - Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Label-free quantitative proteomics of EGFP-Ataxin-3 84Q transgenic zebrafish treated with vehicle and sodium valproate. A Triplicate analyses of vehicle and valproate treated transgenic zebrafish identified common and unique proteins. B Gene ontology (GO) annotation revealed small differences in the identification of proteins, with more proteins (9%) with hydrolase function, while less proteins (3%) were categorized to have carrier activity. C Ingenuity Pathway Analysis (IPA) predicted activation and inhibition of sirtuin signaling and EIF2 signaling pathways respectively upon valproate treatment of transgenic zebrafish expressing EGFP-Ataxin-3 84Q. Blue indicates IPA predicted inhibition and orange indicates predicted activation of categorised biological function and canonical pathways. D Predicted upregulation and downregulation of proteins associated with the sirtuin signaling pathway. Green indicates downregulation (0.67-fold) and red indicates upregulation (1.5-fold) of proteins in valproate treated EGFP-Ataxin-3 84Q zebrafish compared to the vehicle controls

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Mol. Brain